Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Literature DB >> 26056345

Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Bradley A Maron¹, Jane A Leopold².

Abstract

Entities: Chemical Disease Gene Species

Keywords: aldosterone; angiotensins; catecholamines; heart ventricles; hypertension; pulmonary

Mesh：

Substances：

Year: 2015 PMID： 26056345 PMCID： PMC4465126 DOI： 10.1161/CIRCULATIONAHA.114.006980

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

100 in total

1. Dissecting the role of g-protein-coupled receptor kinase 2 for excitation-contraction coupling.

Authors: Christoph Maack
Journal: Circulation Date: 2012-04-10 Impact factor: 29.690

2. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.

Authors: Lahouaria Hadri; Razmig G Kratlian; Ludovic Benard; Bradley A Maron; Peter Dorfmüller; Dennis Ladage; Christophe Guignabert; Kiyotake Ishikawa; Jaume Aguero; Borja Ibanez; Irene C Turnbull; Erik Kohlbrenner; Lifan Liang; Krisztina Zsebo; Marc Humbert; Jean-Sébastien Hulot; Yoshiaki Kawase; Roger J Hajjar; Jane A Leopold
Journal: Circulation Date: 2013-06-26 Impact factor: 29.690

3. Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.

Authors: N W Morrell; S M Danilov; K B Satyan; K G Morris; K R Stenmark
Journal: Cardiovasc Res Date: 1997-05 Impact factor: 10.787

Review 4. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors: K P Minneman
Journal: Pharmacol Rev Date: 1988-06 Impact factor: 25.468

5. Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors: Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal: Am J Respir Crit Care Med Date: 2006-08-03 Impact factor: 21.405

Review 6. Regulation of pulmonary vascular tone.

Authors: P J Barnes; S F Liu
Journal: Pharmacol Rev Date: 1995-03 Impact factor: 25.468

7. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.

Authors: Bradley A Maron; Ying-Yi Zhang; Kevin White; Stephen Y Chan; Diane E Handy; Christopher E Mahoney; Joseph Loscalzo; Jane A Leopold
Journal: Circulation Date: 2012-07-11 Impact factor: 29.690

8. Cervical ganglion block attenuates the progression of pulmonary hypertension via nitric oxide and arginase pathways.

Authors: Sungwon Na; Ok Soo Kim; Sungwoo Ryoo; Tae Dong Kweon; Yong Seon Choi; Hyo Sup Shim; Young Jun Oh
Journal: Hypertension Date: 2013-12-09 Impact factor: 10.190

9. Sympathetic reinnervation of unilaterally denervated rat lung.

Authors: T Takachi; M Maeda; T Shirakusa; Y Hayashida
Journal: Acta Physiol Scand Date: 1995-05

10. Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension.

Authors: C L McGowan; J S Swiston; C F Notarius; S Mak; B L Morris; P E Picton; J T Granton; J S Floras
Journal: Heart Date: 2009-01-16 Impact factor: 5.994

35 in total

Review 1. New and Emerging Therapies for Pulmonary Arterial Hypertension.

Authors: Edda Spiekerkoetter; Steven M Kawut; Vinicio A de Jesus Perez
Journal: Annu Rev Med Date: 2018-09-14 Impact factor: 13.739

2. Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis.

Authors: Bradley A Maron
Journal: Circulation Date: 2016-05-11 Impact factor: 29.690

Review 3. Fibroblasts and the extracellular matrix in right ventricular disease.

Authors: Nikolaos G Frangogiannis
Journal: Cardiovasc Res Date: 2017-10-01 Impact factor: 10.787

4. Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.

Authors: Eric D Austin; James West; James E Loyd; Anna R Hemnes
Journal: Am J Respir Crit Care Med Date: 2017-01-01 Impact factor: 21.405

Review 5. Pulmonary Artery Denervation: Update on Clinical Studies.

Authors: Hang Zhang; Shao-Liang Chen
Journal: Curr Cardiol Rep Date: 2019-09-05 Impact factor: 2.931

Review 6. GPCRs in pulmonary arterial hypertension: tipping the balance.

Authors: Jean Iyinikkel; Fiona Murray
Journal: Br J Pharmacol Date: 2018-04-17 Impact factor: 8.739

7. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.

Authors: Ahmed U Fayyaz; William D Edwards; Joseph J Maleszewski; Ewa A Konik; Hilary M DuBrock; Barry A Borlaug; Robert P Frantz; Sarah M Jenkins; Margaret M Redfield
Journal: Circulation Date: 2017-12-15 Impact factor: 29.690